NDD Europe is the only European industry-focused meeting dedicated to neurodegenerative drug developers.
NDD Europe will host the field's most important thought-leaders and stakeholders and has been designed to help scientists and business leaders from the most innovative and active organisations in this space to overcome their challenges faced during their neurodegenerative research.
Delegates attending the summit are actively seeking support of service providers specialising in neurodegeneration enabling them to:
|Showcase your high quality preclinical models and novel model innovations|
|Introduce the latest neurodegeneration blood-based biomarker technologies|
|Streamline and optimize their preclinical and clinical trial design|
|Demonstrate how your blood-brain barrier technology can help to delivering targeted therapeutics safely and efficiently across the blood-brain barrier|
|Showcase your neurodegeneration expertise and establish your credibility as a high quality research partner|
There are vast networking opportunities at NDD Europe to help you improve your understanding of the neurodegeneration landscape to identify the right connections to make in the fields most active companies and allow you to network with new clients.